" class="no-js "lang="en-US"> 3Z Archives - Pharmtech Focus
Friday, January 27, 2023

Sort by:

Date

Top Post

ProPharma Acquires UK Based Digital Lab Consulting

ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]

3Z Closes $2 Million Funding for Preclinical Development of Novel ADHD and Insomnia Therapeutics Identified by 3Z´s Zebrafish Drug Discovery Platform

3Z, a Reykjavik based drug discovery company is pleased to announce the closure of a $2 million funding round […]

  1. Kinnate Biopharma Adds Global Business and Oncology Expertise to Board of Directors Read more
  2. Ascletis Announces IND Approval of Oral Viral Polymerase Inhibitor ASC10 for Monkeypox Indication Read more
  3. New AI Tool Makes Speedy Gene Editing Possible Read more
  4. European Medicines Agency accepts Marketing Authorization Application for lecanemab as treatment for early Alzheimer’s disease Read more
  5. Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome Read more